Milestone submitted NDA to FDA for etripamil and presented findings at a conference in Boston.

The entities involved

• Boston →

  capital and largest city of Massachusetts, United States

  • The Federal Aviation Administration is managing air traffic operations at Boston Logan Airport.Mon 17:34
  • Modulate leverages benchmarks set by Hugging Face.Mon 17:24
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Milestone →

  American record label

  • FDA accepted Milestone's response to the Complete Response Letter (CRL).Thu 14:06
• Wells Fargo →

  American multinational banking and financial services company

  • Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Mon 16:33
  • Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28

Related events

• Data was presented in Athens supporting a future U.S. NDA submission to the FDA.Sep 4